BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2018 2:57:35 PM | Browse: 792 | Download: 1002
 |
Received |
|
2018-06-09 08:28 |
|
Peer-Review Started |
|
2018-06-10 13:55 |
|
To Make the First Decision |
|
2018-07-10 09:28 |
|
Return for Revision |
|
2018-07-12 06:52 |
|
Revised |
|
2018-08-08 06:38 |
|
Second Decision |
|
2018-08-30 08:49 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2018-08-30 17:28 |
|
Articles in Press |
|
2018-08-30 17:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2018-09-10 17:24 |
|
Typeset the Manuscript |
|
2018-10-22 01:22 |
|
Publish the Manuscript Online |
|
2018-10-26 14:57 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tsung-Jung Lin, Hsi-Chang Lee, Chih-Lin Lin, Chung-Kwe Wang, Kuan-Yang Chen and Deng-Chyang Wu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kuan-Yang Chen, MA, Attending Doctor, Department of Gastroenterology, Taipei City Hospital, 11F., No.10, Sec. 4, Renai Rd., Da-an Dist, Taipei 10629, Taiwan. daa13@tpech.gov.tw |
| Key Words |
Helicobacter pylori; Cytochrome P450 2C19; Interleukin-1β; Hybrid therapy; Rabeprazole |
| Core Tip |
In this study, we investigated the efficacy of hybrid therapy as a first-line treatment for Helicobacter pylori eradication and evaluated the independent predictor associated with eradication efficacy, including cytochrome P450 2C19, interleukin-1β (IL-1β)-511 polymorphism and antibiotic resistance. This study is pilot work investigating the impact of the IL-1β-511 polymorphism on the eradication rate of hybrid therapy. |
| Publish Date |
2018-10-26 14:57 |
| Citation |
Lin TJ, Lee HC, Lin CL, Wang CK, Chen KY, Wu DC. CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication. World J Clin Cases 2018; 6(12): 514-520 |
| URL |
http://www.wjgnet.com/2307-8960/full/v6/i12/514.htm |
| DOI |
http://dx.doi.org/10.12998/wjcc.v6.i12.514 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
